News
02-25-2025, 07:25 PM
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) designed to stimulate immune-mediated eradication of tumors.
More... (https://www.news-medical.net/news/20250225/New-antibody-toxin-conjugate-designed-to-stimulate-immune-mediated-eradication-of-tumors.aspx)
More... (https://www.news-medical.net/news/20250225/New-antibody-toxin-conjugate-designed-to-stimulate-immune-mediated-eradication-of-tumors.aspx)